(Q42478389)

1 November 2017

Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats (English)

1 reference

1 November 2017

Kosasa T

1

1 reference

1 November 2017

Kuriya Y

series ordinal

2

1 reference

1 November 2017

Matsui K

series ordinal

3

1 reference

1 November 2017

Yamanishi Y

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

European Journal of Pharmacology

1 November 2017

1 reference

1 November 2017

380

1 reference

1 November 2017

2-3

1 reference

1 November 2017

101-107

1 reference

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

Effect of NIK-247 on basal concentrations of extracellular acetylcholine in the cerebral cortex of conscious, freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900545-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00545-2

1 reference

1 November 2017

1 reference